SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 4th, 2015 • Cyclacel Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 4th, 2015 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 3, 2015, between Cyclacel Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
STRICTLY CONFIDENTIAL Spiro Rombotis President and Chief Executive Officer Cyclacel Pharmaceuticals, Inc.Exclusive Agency Agreement • March 4th, 2015 • Cyclacel Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 4th, 2015 Company Industry Jurisdiction